TB

Thomas P. Bobinski

MT Mirati Therapeutics: 4 patents #4 of 37Top 15%
📍 San Diego, CA: #354 of 4,447 inventorsTop 8%
🗺 California: #3,757 of 65,961 inventorsTop 6%
Overall (2022): #26,316 of 548,613Top 5%
5
Patents 2022

Issued Patents 2022

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
11492351 MTA-cooperative PRMT5 inhibitors Christopher Ronald Smith, Matthew Arnold Marx, John Michael Ketcham, Aaron Craig Burns, John David Lawson +3 more 2022-11-08
11485738 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Matthew Arnold Marx, Matthew Lee, Aaron Craig Burns, Nidhi Arora, James Gail Christensen +1 more 2022-11-01
11479551 MTA-cooperative PRMT5 inhibitors Christopher Ronald Smith, Matthew Arnold Marx, John Michael Ketcham, Aaron Craig Burns, John David Lawson +3 more 2022-10-25
11248004 Substituted isoquinolines as rock kinase inhibitors Matthew Lee, Anthony Joseph Varano, Jr. 2022-02-15
11220509 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Matthew Arnold Marx, Matthew Lee, Aaron Craig Burns, Nidhi Arora, James Gail Christensen +1 more 2022-01-11